ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Group Lobby To Add $200 Mil. To Cancer Budget

April 26, 1991

NCI Intends To Extend OSCC Two More Years

October 3, 1986

In Brief: Rhode Island, Los Angeles Approved For NCI Community Implementation Awards; Hawaii Close

July 8, 1977

Einhorn Begins Term; Salmon, Blum Honored; Gore Gives Award To IntraMall, Piloted At NCI.

May 26, 2000

In Brief: Urologist Appointed To NCAB; Stovall Named To US Pharmacopeia Oncology Advisory Panel

September 8, 1995

Low-Dose Warfarin Prevents Blood Clots, NIH Study Finds

February 28, 2003